We are looking for a motivated graduate student to join our team to develop radiopharmaceuticals for high-lethality cancers. The graduate student will have the opportunity to design, synthesize, and radiolabel pharmacophores (e.g., peptides, drug inhibitors, antibodies, antibody mimetics, etc.) to improve the diagnosis and treatment of solid and hematological malignancies. Our research involves the use of human and mouse models, patient-derived samples, and cutting-edge imaging technologies.
The Lau lab is a part of the Department of Integrative Oncology, a world-class interdisciplinary research unit at BC Cancer, and the Faculty of Medicine, UBC. The Lau lab has a strong interest in translational cancer research and experience with first-in-human clinical trials. The graduate student will work with and learn from chemists, radiochemists, molecular biologists, medical physicists, and nuclear medicine physicians. The graduate student is expected to participate in all aspects of project development, planning, and collaboration.
The graduate student will enroll in the Interdisciplinary Oncology Program (IOP; www.iop.ca) at The University of British Columbia (www.grad.ubc.ca). Please note, no applicant will be admitted into the IOP program without a commitment from a research supervisor.
Qualified candidates should have a bachelor's degree preferably in molecular biology, chemistry, biochemistry, or pharmacology. Interested candidates should send a statement of research interest, curriculum vitae, transcripts, and contact details for 3 referees to:
Joseph Lau, PhD
Scientist, Integrative Oncology, BC Cancer
Assistant Professor, Radiology, UBC
Email: jlau[at]bccrc[dot]ca